annual CFF:
$478.06M-$166.02M(-25.78%)Summary
- As of today (June 22, 2025), IONS annual cash flow from financing activities is $478.06 million, with the most recent change of -$166.02 million (-25.78%) on December 31, 2024.
- During the last 3 years, IONS annual CFF has risen by +$232.13 million (+94.39%).
- IONS annual CFF is now -25.78% below its all-time high of $644.08 million, reached on December 31, 2023.
Performance
IONS Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$2.20M+$46.31M(+104.98%)Summary
- As of today (June 22, 2025), IONS quarterly cash flow from financing activities is $2.20 million, with the most recent change of +$46.31 million (+104.98%) on March 31, 2025.
- Over the past year, IONS quarterly CFF has dropped by -$21.37 million (-90.67%).
- IONS quarterly CFF is now -99.56% below its all-time high of $496.05 million, reached on September 30, 2024.
Performance
IONS quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$456.69M-$21.37M(-4.47%)Summary
- As of today (June 22, 2025), IONS TTM cash flow from financing activities is $456.69 million, with the most recent change of -$21.37 million (-4.47%) on March 31, 2025.
- Over the past year, IONS TTM CFF has increased by +$281.12 million (+160.12%).
- IONS TTM CFF is now -29.09% below its all-time high of $644.08 million, reached on December 31, 2023.
Performance
IONS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
IONS Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.8% | -90.7% | +160.1% |
| 3 y3 years | +94.4% | +130.0% | +85.5% |
| 5 y5 years | +378.0% | +102.3% | +946.7% |
IONS Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -25.8% | +964.6% | -99.6% | +104.3% | -29.1% | +780.2% |
| 5 y | 5-year | -25.8% | +180.1% | -99.6% | +100.4% | -29.1% | +176.6% |
| alltime | all time | -25.8% | +180.1% | -99.6% | +100.4% | -29.1% | +176.6% |
IONS Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $2.20M(-105.0%) | $456.69M(-4.5%) |
| Dec 2024 | $478.06M(-25.8%) | -$44.12M(-108.9%) | $478.06M(-15.1%) |
| Sep 2024 | - | $496.05M(>+9900.0%) | $562.90M(+1527.6%) |
| Jun 2024 | - | $2.56M(-89.2%) | $34.58M(-80.3%) |
| Mar 2024 | - | $23.57M(-42.1%) | $175.56M(-72.7%) |
| Dec 2023 | $644.08M(-1264.8%) | $40.72M(-226.2%) | $644.08M(+16.6%) |
| Sep 2023 | - | -$32.27M(-122.5%) | $552.34M(-5.8%) |
| Jun 2023 | - | $143.54M(-70.8%) | $586.44M(+32.0%) |
| Mar 2023 | - | $492.09M(-1064.5%) | $444.12M(-903.2%) |
| Dec 2022 | -$55.30M(-122.5%) | -$51.02M(-2881.8%) | -$55.30M(-17.2%) |
| Sep 2022 | - | $1.83M(+50.9%) | -$66.77M(-0.6%) |
| Jun 2022 | - | $1.22M(-116.6%) | -$67.14M(-127.3%) |
| Mar 2022 | - | -$7.33M(-88.3%) | $246.19M(+0.1%) |
| Dec 2021 | $245.93M(-141.2%) | -$62.49M(-4386.0%) | $245.93M(-215.4%) |
| Sep 2021 | - | $1.46M(-99.5%) | -$213.06M(+4.7%) |
| Jun 2021 | - | $314.54M(-4251.3%) | -$203.58M(-60.1%) |
| Mar 2021 | - | -$7.58M(-98.5%) | -$509.69M(-14.6%) |
| Dec 2020 | -$596.61M(-696.5%) | -$521.48M(-4868.0%) | -$596.61M(+967.2%) |
| Sep 2020 | - | $10.94M(+29.7%) | -$55.90M(-30.1%) |
| Jun 2020 | - | $8.44M(-108.9%) | -$80.02M(+48.3%) |
| Mar 2020 | - | -$94.50M(-591.6%) | -$53.94M(-153.9%) |
| Dec 2019 | $100.02M(-79.0%) | $19.23M(-245.9%) | $100.02M(+10.6%) |
| Sep 2019 | - | -$13.17M(-138.2%) | $90.44M(-19.0%) |
| Jun 2019 | - | $34.51M(-42.0%) | $111.69M(-78.9%) |
| Mar 2019 | - | $59.46M(+516.4%) | $530.10M(+11.4%) |
| Dec 2018 | $475.87M(+107.7%) | $9.65M(+19.4%) | $475.87M(+1.1%) |
| Sep 2018 | - | $8.08M(-98.2%) | $470.48M(-22.9%) |
| Jun 2018 | - | $452.92M(+8570.0%) | $609.97M(+284.2%) |
| Mar 2018 | - | $5.22M(+22.7%) | $158.76M(-30.7%) |
| Dec 2017 | $229.09M(+1910.6%) | $4.26M(-97.1%) | $229.09M(-0.9%) |
| Sep 2017 | - | $147.57M(+8519.9%) | $231.28M(+162.1%) |
| Jun 2017 | - | $1.71M(-97.7%) | $88.25M(+2.5%) |
| Mar 2017 | - | $75.55M(+1071.6%) | $86.06M(+655.3%) |
| Dec 2016 | $11.39M(-53.9%) | $6.45M(+41.9%) | $11.39M(-31.6%) |
| Sep 2016 | - | $4.54M(-1054.4%) | $16.66M(+35.6%) |
| Jun 2016 | - | -$476.00K(-154.2%) | $12.28M(-12.7%) |
| Mar 2016 | - | $879.00K(-92.5%) | $14.08M(-43.1%) |
| Dec 2015 | $24.73M(-58.5%) | $11.71M(+6914.4%) | $24.73M(-60.7%) |
| Sep 2015 | - | $167.00K(-87.3%) | $62.89M(-2.4%) |
| Jun 2015 | - | $1.32M(-88.6%) | $64.41M(+4.2%) |
| Mar 2015 | - | $11.53M(-76.9%) | $61.80M(+3.7%) |
| Dec 2014 | $59.59M(-73.8%) | $49.88M(+2865.6%) | $59.59M(+357.2%) |
| Sep 2014 | - | $1.68M(-230.6%) | $13.03M(-54.6%) |
| Jun 2014 | - | -$1.29M(-113.8%) | $28.71M(-87.4%) |
| Mar 2014 | - | $9.31M(+179.9%) | $227.99M(+0.1%) |
| Dec 2013 | $227.72M(+482.0%) | $3.33M(-80.8%) | $227.72M(+2.0%) |
| Sep 2013 | - | $17.36M(-91.2%) | $223.25M(-7.1%) |
| Jun 2013 | - | $197.99M(+2087.8%) | $240.29M(+380.3%) |
| Mar 2013 | - | $9.05M(-886.3%) | $50.03M(+27.9%) |
| Dec 2012 | $39.13M(-5922.9%) | -$1.15M(-103.3%) | $39.13M(-4.2%) |
| Sep 2012 | - | $34.40M(+344.6%) | $40.87M(+632.2%) |
| Jun 2012 | - | $7.74M(-517.5%) | $5.58M(-410.6%) |
| Mar 2012 | - | -$1.85M(-416.8%) | -$1.80M(+167.4%) |
| Dec 2011 | -$672.00K(-114.3%) | $585.00K(-165.9%) | -$672.00K(-147.4%) |
| Sep 2011 | - | -$888.00K(-347.4%) | $1.42M(-25.6%) |
| Jun 2011 | - | $359.00K(-149.3%) | $1.91M(-51.2%) |
| Mar 2011 | - | -$728.00K(-127.2%) | $3.90M(-17.0%) |
| Dec 2010 | $4.70M(-97.7%) | $2.67M(-767.1%) | $4.70M(+3.0%) |
| Sep 2010 | - | -$401.00K(-117.0%) | $4.56M(-55.1%) |
| Jun 2010 | - | $2.35M(+3361.8%) | $10.15M(+16.8%) |
| Mar 2010 | - | $68.00K(-97.3%) | $8.69M(-95.7%) |
| Dec 2009 | $202.00M(+87.8%) | $2.54M(-51.1%) | $202.00M(-3.2%) |
| Sep 2009 | - | $5.19M(+482.4%) | $208.78M(+1.5%) |
| Jun 2009 | - | $891.00K(-99.5%) | $205.74M(-10.6%) |
| Mar 2009 | - | $193.38M(+1975.4%) | $230.02M(+113.8%) |
| Dec 2008 | $107.58M | $9.32M(+333.4%) | $107.58M(+6.5%) |
| Sep 2008 | - | $2.15M(-91.5%) | $101.02M(-9.5%) |
| Jun 2008 | - | $25.17M(-64.5%) | $111.67M(+3349.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | $70.95M(+2480.0%) | $3.24M(-92.6%) |
| Dec 2007 | $43.65M(-70.8%) | $2.75M(-78.5%) | $43.65M(-62.4%) |
| Sep 2007 | - | $12.80M(-115.4%) | $116.19M(+8.5%) |
| Jun 2007 | - | -$83.27M(-174.8%) | $107.05M(-58.8%) |
| Mar 2007 | - | $111.36M(+47.9%) | $260.04M(+74.0%) |
| Dec 2006 | $149.46M(+297.5%) | $75.29M(+1957.6%) | $149.46M(+108.3%) |
| Sep 2006 | - | $3.66M(-94.8%) | $71.76M(-34.7%) |
| Jun 2006 | - | $69.73M(+8771.4%) | $109.88M(+205.3%) |
| Mar 2006 | - | $786.00K(-132.6%) | $35.99M(-4.3%) |
| Dec 2005 | $37.60M(+209.4%) | -$2.41M(-105.8%) | $37.60M(-18.2%) |
| Sep 2005 | - | $41.77M(-1105.6%) | $45.95M(+596.0%) |
| Jun 2005 | - | -$4.15M(-273.5%) | $6.60M(-51.1%) |
| Mar 2005 | - | $2.39M(-59.7%) | $13.50M(+11.1%) |
| Dec 2004 | $12.15M(-71.0%) | $5.94M(+145.5%) | $12.15M(-45.4%) |
| Sep 2004 | - | $2.42M(-11.8%) | $22.24M(-13.9%) |
| Jun 2004 | - | $2.74M(+161.7%) | $25.84M(-25.3%) |
| Mar 2004 | - | $1.05M(-93.5%) | $34.59M(-17.4%) |
| Dec 2003 | $41.85M(-67.7%) | $16.03M(+166.3%) | $41.85M(-23.0%) |
| Sep 2003 | - | $6.02M(-47.6%) | $54.34M(+19.6%) |
| Jun 2003 | - | $11.49M(+38.2%) | $45.44M(-64.9%) |
| Mar 2003 | - | $8.31M(-70.8%) | $129.43M(-0.1%) |
| Dec 2002 | $129.59M(-45.3%) | $28.51M(-1090.0%) | $129.59M(-43.5%) |
| Sep 2002 | - | -$2.88M(-103.0%) | $229.21M(-27.0%) |
| Jun 2002 | - | $95.49M(+1027.0%) | $314.17M(+28.0%) |
| Mar 2002 | - | $8.47M(-93.4%) | $245.40M(+3.5%) |
| Dec 2001 | $237.04M(+92.9%) | $128.13M(+56.1%) | $237.04M(+87.1%) |
| Sep 2001 | - | $82.08M(+207.2%) | $126.70M(+180.4%) |
| Jun 2001 | - | $26.72M(>+9900.0%) | $45.18M(-19.4%) |
| Mar 2001 | - | $116.00K(-99.3%) | $56.07M(-54.4%) |
| Dec 2000 | $122.88M(+92.3%) | $17.79M(+3110.8%) | $122.88M(-6.8%) |
| Sep 2000 | - | $554.00K(-98.5%) | $131.80M(-7.0%) |
| Jun 2000 | - | $37.62M(-43.8%) | $141.64M(+8.7%) |
| Mar 2000 | - | $66.93M(+150.7%) | $130.33M(+104.0%) |
| Dec 1999 | $63.90M(+323.2%) | $26.70M(+156.7%) | $63.90M(+70.4%) |
| Sep 1999 | - | $10.40M(-60.5%) | $37.50M(+41.5%) |
| Jun 1999 | - | $26.30M(+5160.0%) | $26.50M(+85.3%) |
| Mar 1999 | - | $500.00K(+66.7%) | $14.30M(-5.3%) |
| Dec 1998 | $15.10M(-58.9%) | $300.00K(-150.0%) | $15.10M(-62.6%) |
| Sep 1998 | - | -$600.00K(-104.3%) | $40.40M(-4.0%) |
| Jun 1998 | - | $14.10M(+984.6%) | $42.10M(+12.0%) |
| Mar 1998 | - | $1.30M(-94.9%) | $37.60M(+2.5%) |
| Dec 1997 | $36.70M(+59.6%) | $25.60M(+2227.3%) | $36.70M(+10.2%) |
| Sep 1997 | - | $1.10M(-88.5%) | $33.30M(+4.7%) |
| Jun 1997 | - | $9.60M(+2300.0%) | $31.80M(+37.1%) |
| Mar 1997 | - | $400.00K(-98.2%) | $23.20M(+0.9%) |
| Dec 1996 | $23.00M(-54.1%) | $22.20M(-5650.0%) | $23.00M(-16.1%) |
| Sep 1996 | - | -$400.00K(-140.0%) | $27.40M(-44.0%) |
| Jun 1996 | - | $1.00M(+400.0%) | $48.90M(-3.6%) |
| Mar 1996 | - | $200.00K(-99.2%) | $50.70M(+1.2%) |
| Dec 1995 | $50.10M(+1254.1%) | $26.60M(+26.1%) | $50.10M(+115.9%) |
| Sep 1995 | - | $21.10M(+653.6%) | $23.20M(+866.7%) |
| Jun 1995 | - | $2.80M(-800.0%) | $2.40M(-260.0%) |
| Mar 1995 | - | -$400.00K(+33.3%) | -$1.50M(-140.5%) |
| Dec 1994 | $3.70M(-90.7%) | -$300.00K(-200.0%) | $3.70M(-85.7%) |
| Sep 1994 | - | $300.00K(-127.3%) | $25.80M(-3.0%) |
| Jun 1994 | - | -$1.10M(-122.9%) | $26.60M(-1.8%) |
| Mar 1994 | - | $4.80M(-78.0%) | $27.10M(-32.1%) |
| Dec 1993 | $39.90M(-2760.0%) | $21.80M(+1881.8%) | $39.90M(+138.9%) |
| Sep 1993 | - | $1.10M(-283.3%) | $16.70M(+10.6%) |
| Jun 1993 | - | -$600.00K(-103.4%) | $15.10M(-7.9%) |
| Mar 1993 | - | $17.60M(-1357.1%) | $16.40M(-1193.3%) |
| Dec 1992 | -$1.50M(-102.3%) | -$1.40M(+180.0%) | -$1.50M(-105.0%) |
| Sep 1992 | - | -$500.00K(-171.4%) | $30.30M(-1.0%) |
| Jun 1992 | - | $700.00K(-333.3%) | $30.60M(-41.6%) |
| Mar 1992 | - | -$300.00K(-101.0%) | $52.40M(-18.8%) |
| Dec 1991 | $64.50M | $30.40M(<-9900.0%) | $64.50M(+89.1%) |
| Sep 1991 | - | -$200.00K(-100.9%) | $34.10M(-0.6%) |
| Jun 1991 | - | $22.50M(+90.7%) | $34.30M(+190.7%) |
| Mar 1991 | - | $11.80M | $11.80M |
FAQ
- What is Ionis Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual CFF year-on-year change?
- What is Ionis Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly CFF year-on-year change?
- What is Ionis Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals TTM CFF year-on-year change?
What is Ionis Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of IONS is $478.06M
What is the all time high annual CFF for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual cash flow from financing activities is $644.08M
What is Ionis Pharmaceuticals annual CFF year-on-year change?
Over the past year, IONS annual cash flow from financing activities has changed by -$166.02M (-25.78%)
What is Ionis Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of IONS is $2.20M
What is the all time high quarterly CFF for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly cash flow from financing activities is $496.05M
What is Ionis Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, IONS quarterly cash flow from financing activities has changed by -$21.37M (-90.67%)
What is Ionis Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of IONS is $456.69M
What is the all time high TTM CFF for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high TTM cash flow from financing activities is $644.08M
What is Ionis Pharmaceuticals TTM CFF year-on-year change?
Over the past year, IONS TTM cash flow from financing activities has changed by +$281.12M (+160.12%)